Endometriosis Clinical Trial
Official title:
Does "Aggressivity" of Endometriosis Correlate to Clinical History or Outcomes?
Clinical studies so far have been limited, and larger volume and multi-center studies studies
are needed. The purpose of this pilot study is to look for a clinical correlations between
the aggressivity panel developed from biomarkers thought to affect the progression or
aggressivity of endometriosis, pain and quality of life.
Our goal with the study is find a correlation between the "aggressivity" of endometriosis
with clinical factors determined in our study questionnaires. The "aggressivity panel" was
pioneered by the EndoDiag lab in France, and was created using markers thought to affect the
activity or progression of endometriosis. This information could lead to a better
understanding of the disease, and ultimately lead to more targeted therapies.
If a patient returns for a second surgery we will ask their permission to use their slides
from their first and seconed surgery to compare. The tissue that is being removed during the
surgery as standard of care to make slides for the research study (there will not be an
endometrial biopsy performed for research purposes with the second surgery). The slides from
surgery 1 & surgery 2 will then be compared.
If a clinical correlation is found with the aggressivity panel, the goal would be to create a
local lab and tissue bank here in the United States that could provide a basis for
collaborative national (even international) research. Also, if a correlation is found, future
investigation will look at correlations of the aggressivity panel and fertility outcomes.
Results of this pilot study will help to direct studies of treatment protocols of the various
stages of aggressivity of endometriosis.
The study design is an investigator-initiated pilot, prospective cohort study (Canadian Task
Force, II-3). Patients will not be randomized.
Consecutive subjects from age 14-55 will be recruited and included in the study if they are
seeking treatment of pain and with suspected or known endometriosis. Patients who are
menopausal (either chemically-induced, natural or surgical) will not be included in the
study. Patients who are pregnant are not eligible for surgery, and not eligible to be in the
study. Subjects will be excluded if they are found not to have endometriosis confirmed by
histology. All surgeries are performed at a single institution, St. Mary's Hospital.
An ad hoc sample size calculation is not possible for this pilot study, since we have no
historic data on which to base such a calculation. The goal is to acquire 45 panel results,
as a reasonable amount of data for a pilot study, and given the funding available.
Quality of life (measured by the 100-point scale and by the EHP-5) and pain indices (measured
by the VAS scale) will be measured at up to six different time points: before surgery, six
months after surgery, and one year after each surgery. At each time point you will compare
quality of life and each pain index across the four aggressivity groups of low, moderate,
medium, and high using analysis of variance (ANOVA) or the non-parametric Kruskal-Wallis test
depending on the normality of the distributions. Pairwise comparisons will also be made using
independent students t test or the non-parametric Kolmogorov-Smirnov test depending on the
normality of the distributions.
The follow-up time frame for each surgery will be 1 year. Patients will receive
questionnaires pre op and at 6-months and 1 year for both the first surgery and the second
surgery( if needed). The entire study will take about 4 years, including data analysis and
publication. .
This study is related to IRB #20900. Subjects who consent to participate in this study may
also be consented to participate in 20900. The pre-operative and follow-up questionnaires,
and the standardized tools relating to QOL and depression are the same as in IRB#20900.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01931670 -
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
|
Phase 3 | |
Recruiting |
NCT05648669 -
A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain
|
Phase 3 | |
Completed |
NCT04081532 -
The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain
|
N/A | |
Recruiting |
NCT06101303 -
Endometriosis Pain
|
||
Completed |
NCT04665414 -
Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
|
||
Completed |
NCT03690765 -
Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis
|
||
Recruiting |
NCT05153512 -
ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)
|
||
Active, not recruiting |
NCT04171297 -
Ultrasound Evaluation of the Pelvis in Women With Suspected Endometriosis Scheduled for Laparoscopic Surgery
|
||
Recruiting |
NCT04172272 -
The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures
|
N/A | |
Completed |
NCT04565470 -
Strategies of Self-management of Endometriosis Symptoms
|
||
Completed |
NCT03613298 -
Treatment by HIFU With Focal One® of Posterior Deep Infiltrating Endometriosis Lesions With Intestinal Involvement.
|
N/A | |
Withdrawn |
NCT05568940 -
Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
|
||
Not yet recruiting |
NCT03464799 -
Does Immunotherapy Have a Role in the Management of Endometriosis?
|
||
Active, not recruiting |
NCT03002870 -
Characteristics of Patient Population With Endometriosis
|
N/A | |
Withdrawn |
NCT03272360 -
Endometriosis Biomarker Discovery Study
|
N/A | |
Completed |
NCT02973854 -
Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat
|
||
Recruiting |
NCT02481739 -
Laparoscopic Surgical Management of Endometriosis on Fertility
|
N/A | |
Active, not recruiting |
NCT02754648 -
Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve
|
N/A | |
Completed |
NCT06106932 -
GnRH-a on Angiogenesis of Endometriosis
|
N/A | |
Completed |
NCT02387931 -
Supplementation in Adolescent Girls With Endometriosis
|
Phase 4 |